Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Opiant Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −8 vs. Q1 2022
- Shares held
- 1.86M
- +307.1K (+19.7%) vs. Q1 2022
- Total value
- $22.3M
- −$11.0M (−33.0%) vs. Q1 2022
- New holders
- 3
- 17 more added
- Sold out
- 11
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 20 | $0 | 0.00% | +10+100.0% | Added |
| National Bank of Canada | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 180 | $2.16K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 266 | $3.00K | 0.00% | +266 | New |
| American Research & Management Co. | 300 | $4.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 384 | $5.00K | 0.00% | +132+52.4% | Added |
| Lindbrook Capital, LLC | 500 | $6.00K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,180 | $14.0K | 0.00% | +158+15.5% | Added |
| Tower Research Capital LLC (TRC) | 1,369 | $16.0K | 0.00% | +1,215+789.0% | Added |
| Royal Bank of Canada | 1,400 | $17.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5,500 | $66.0K | 0.00% | +75+1.4% | Added |
| Morgan Stanley | 8,757 | $105.0K | 0.00% | −17,918−67.2% | Reduced |
| D. E. Shaw & Co., Inc. | 10,044 | $120.0K | 0.00% | −6,945−40.9% | Reduced |
| Trexquant Investment LP | 12,219 | $147.0K | 0.01% | +206+1.7% | Added |
| State Street Corp | 13,285 | $159.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,679 | $212.0K | 0.00% | +17,679 | New |
| Perritt Capital Management Inc | 30,500 | $366.0K | 0.22% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 37,056 | $444.0K | 0.00% | −1,776−4.6% | Reduced |
| Northern Trust Corp | 37,426 | $449.0K | 0.00% | +348+0.9% | Added |
| BlackRock Inc. | 39,795 | $477.0K | 0.00% | +4,472+12.7% | Added |
| Geode Capital Management, LLC | 48,560 | $582.0K | 0.00% | +562+1.2% | Added |
| Essex Investment Management Co LLC | 50,405 | $604.0K | 0.10% | +18,365+57.3% | Added |
| Two Sigma Advisers, LP | 74,400 | $892.0K | 0.00% | +1,700+2.3% | Added |
| Parkman Healthcare Partners LLC | 75,632 | $907.0K | 0.33% | +43,075+132.3% | Added |
| Acadian Asset Management LLC | 126,978 | $1.52M | 0.01% | +10,500+9.0% | Added |
| Dimensional Fund Advisors LP | 127,292 | $1.53M | 0.00% | +20,610+19.3% | Added |
| Stonepine Capital Management, LLC | 152,278 | $1.83M | 0.85% | +152,278 | New |
| Vanguard Group Inc | 187,158 | $2.24M | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 193,415 | $2.32M | 0.00% | +15,400+8.7% | Added |
| Apis Capital Advisors, LLC | 196,000 | $2.35M | 2.65% | +84,000+75.0% | Added |
| Wells Fargo & Company | 203,231 | $2.44M | 0.00% | −1,995−1.0% | Reduced |
| HealthInvest Partners AB | 210,000 | $2.52M | 5.80% | +192,000+1,066.7% | Added |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −117,865−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −16,084−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −15,042−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −13,584−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −13,550−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,577−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −7,466−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,050−100.0% | Sold out |
| Sage Private Wealth Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |